I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Immuno-priming durvalumab with bevacizumab in HER2-negative..:
Miguel Quintela-Fandino
;
Esther Holgado
;
Luis Manso
...
http://link.springer.com/article/10.1186/s13058-020-01362-y. , 2020
Link:
https://doi.org/10.1186/s13058-020-01362-y
RT Journal T1
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:3f6add655fbe4b0d92de37dd9a97fca3&Exemplar=1&LAN=DE A1 Miguel Quintela-Fandino A1 Esther Holgado A1 Luis Manso A1 Serafin Morales A1 Begoña Bermejo A1 Ramon Colomer A1 Juan V. Apala A1 Raquel Blanco A1 Manuel Muñoz A1 Eduardo Caleiras A1 Vega Iranzo A1 Mario Martinez A1 Orlando Dominguez A1 Javier Hornedo A1 Lucia Gonzalez-Cortijo A1 Javier Cortes A1 Ariadna Gasol Cudos A1 Diego Malon A1 Antonio Lopez-Alonso A1 María C. Moreno-Ortíz A1 Silvana Mouron A1 Santos Mañes PB BMC YR 2020 K1 Durvalumab K1 Bevacizumab K1 HER2-negative breast cancer K1 Vascular normalization K1 Immuno-priming K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF http://link.springer.com/article/10.1186/s13058-020-01362-y LK http://dx.doi.org/https://doi.org/10.1186/s13058-020-01362-y DO https://doi.org/10.1186/s13058-020-01362-y SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)